In addition, osteopontin released by cancer-associated mesothelial cells has been shown to induce chemoresistance via activation of CD44, PI3K-AKT signaling, and ABC drug transporter in ovarian cancer cells in vitro (40). This evidence concerns the gene CD44 and ovarian carcinoma.